Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This open, monocentric study is designed to investigate plasma concentrations of certain
catechins after topical application of Veregen 15% ointment to genital or perianal warts in
comparison to catechin plasma concentrations after oral intake of a defined dose of green tea
beverage. The study is intended to demonstrate that topical administration of Veregen 15%
induces catechin plasma concentrations lower or equivalent to those that can be reached with
normal consumption of green tea.